av/myovant-sciences--big.svg

NYSE:MYOV

Myovant Sciences Ltd.

  • Stock

USD

Last Close

26.99

09/03 21:01

Market Cap

2.62B

Beta: 2.15

Volume Today

2.26M

Avg: 1.09M

PE Ratio

−14.22

PFCF: −9.69

  • industry

    Biotechnology
  • exchange

    New York Stock Exchange
  • website

    myovant.com
  • ipo date

    Oct 27, 2016
  • full time employees

    579
  • currency

    USD

Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with ...Show More

Earnings

Earnings per Share (Estimate*)

-1-0.8-0.6-0.4-0.22016-06-302018-02-132019-08-062021-02-112022-07-27

Revenue (Estimate*)

50M100M150M2016-06-302018-02-132019-08-062021-02-112022-07-27

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.